Prkdc Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| DNA-Dependent Protein Kinase Catalytic Subunit | |
|---|---|
| Protein Name | DNA-PKcs |
| Gene | PRKDC |
| UniProt ID | P78527 |
| PDB Structure | 1JQT, 3KGV |
| Molecular Weight | 469 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | PI3/PI4-related family |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
DNA-PKcs is a large serine/threonine protein kinase consisting of 4,127 amino acids. It contains a kinase domain at the C-terminus and a DNA-binding domain at the N-terminus. DNA-PKcs forms a complex with Ku70/Ku80 heterodimer.
DNA-PKcs functions in:
Defects in DNA-PKcs impair DNA repair, leading to accumulation of DNA damage in neurons. This contributes to neurodegeneration in AD, PD, and ALS. DNA-PK inhibitors are being explored as therapeutic agents.
DNA-PK inhibitors (e.g., NU7441, KU-0060648) are in development for cancer and potentially for neurodegeneration.
The study of Prkdc Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.